Skip to main content

Table 4 Case attributes by type of substances (N = 664)

From: Evaluation of performance-enhancing drugs seized by Israeli enforcement agencies 2012–2017: implications for policy and regulatory change

Type

AASa (N = 539)

Others Substancesb (N = 125)

df

χ 2

Sig

N (%)

N (%)

Gender

Male

489 (90.7)

115 (92)

1

.201

.065

Female

50 (9.3)

10 (8.0)

   

Year

2012

22 (4.1)

7 (5.6)

5

19.701

.001

2013

59 (11,0)

23 (18.4)

   

2014

158 (29.3)

24 (19.2)

   

2015

87 (16.1)

21 (16.8)

   

2016

112 (20.8)

39 (31.2)

   

2017

101 (18.7)

11 (8.8)

   

Place of Seizure

Land and Air ports of entry

118 (21.9)

10 (8.0)

3

13.594

.004

Mail and Packages processing centers

207 (38.4)

51 (40.8)

   

Private premises

181 (33.6)

55 (44.0)

   

Public or commercial properties

33 (6.1)

9 (7.2)

   
  1. aAnabolic Androgenic Steroids
  2. bWADA prohibited substances from the following categories: Adrenergic and sympathomimetic agent; Diuretics, Sodium and potassium supplements; Hormones, Growth hormones, and hormone releasing agent; Post-cycle and adverse effects treatment agents and site-enhancing oils